Targeted delivery of a ligand–drug conjugate via formyl peptide receptor 1 through cholesterol-dependent endocytosis
G protein-coupled receptors (GPCRs) undergo ligand-induced internalization that carries
the cognate ligands into intracellular compartments. The present study explores this property …
the cognate ligands into intracellular compartments. The present study explores this property …
[HTML][HTML] In Silico Conformation of the Drug Colchicine into Tubulin Models and Acute Phytotoxic Activity on Cucumis sativus Radicles
OA Peña-Morán, J Jiménez-Pérez, L Cerón-Romero… - Plants, 2022 - mdpi.com
Many tests are used to determine the toxic activity of miscellaneous substances, and those
that are simple, fast, and inexpensive are useful for screening compounds with applications …
that are simple, fast, and inexpensive are useful for screening compounds with applications …
Structural Perspective of Benzophenones Targeting Tubulin as Anticancer Agents
Cancer is the leading cause of death and the most significant determinant of life expectancy
in almost every country in this twenty-first century. According to the World Health …
in almost every country in this twenty-first century. According to the World Health …
Combretastatin A4-loaded Poly (Lactic-co-glycolic Acid)/Soybean Lecithin Nanoparticles with Enhanced Drug Dissolution Rate and Antiproliferation Activity
Y Cao, AMQ Ahmed, HH Du, W Sun, X Lu… - Current Drug …, 2022 - ingentaconnect.com
Objective: This study aimed to prepare combretastatin A4 (CA4)-loaded nanoparticles (CA4
NPs) using poly (lactic-co-glycolic acid)(PLGA) and soybean lecithin (Lipoid S100) as …
NPs) using poly (lactic-co-glycolic acid)(PLGA) and soybean lecithin (Lipoid S100) as …
Chemical Biology Studies on Aplyronine A, A PPI-Inducing Antitumor Macrolide from Sea Hare
M Kita - New Tide of Natural Product Chemistry, 2023 - Springer
The antitumor macrolide aplyronine A (ApA) disturbs microtubule (MT) dynamics by inducing
the protein–protein interaction (PPI) between actin and tubulin. However, the detailed …
the protein–protein interaction (PPI) between actin and tubulin. However, the detailed …
Cell-derived nanoplatforms for cancer therapy
PMP Lins - 2021 - teses.usp.br
Nanomaterials are promising platforms for cancer therapy due to their innate passive
targeting. The success of nanomaterials into the clinics depends on their blood circulation …
targeting. The success of nanomaterials into the clinics depends on their blood circulation …
[HTML][HTML] STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models
G Rozic, L Paukov, Z Cohen, I Shapira, A Duek… - Oncotarget, 2018 - ncbi.nlm.nih.gov
STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in
vivo multiple myeloma models - PMC Back to Top Skip to main content NIH NLM Logo Access …
vivo multiple myeloma models - PMC Back to Top Skip to main content NIH NLM Logo Access …
The current perspectives of nanoparticles in cellular and organ-specific drug targeting in biological system
A Muthuraman - Nanostructures for the engineering of cells, tissues and …, 2018 - Elsevier
The current perspectives on the nanoparticle have proved that it plays a promising role in
the field of nanomedicine. The basic understanding of nanoparticle action in the biological …
the field of nanomedicine. The basic understanding of nanoparticle action in the biological …
Développement d'anticorps mono ou bi-conjugués innovants pour le ciblage des cancers du sein triple négatifs
J Most - 2023 - theses.hal.science
Les cancers du sein triple négatifs, un sous-type de cancer du sein présentant un déficit de
trois récepteurs communément utilisés en thérapie, représentent un important défi …
trois récepteurs communément utilisés en thérapie, représentent un important défi …
Planejamento in silico de cumarinas como possíveis inibidores da Cinesina Eg5
JPS Souza - 2021 - lume.ufrgs.br
O câncer de pulmão é uma das maiores causas de morte no mundo, sendo responsável por
aproximadamente 2, 1 milhões de novos casos ao ano. No Brasil, é o quarto tipo de câncer …
aproximadamente 2, 1 milhões de novos casos ao ano. No Brasil, é o quarto tipo de câncer …